重症SARS-CoV-2感染发病七天内入住ICU患者死亡率增高
这项多中心回顾性研究纳入2020年2月20日至4月24日四家ICU收治的379例COVID-19患者,按发病至ICU入住时间分组。发病7天内入住者28天死亡率为37%,8至14天为21%,超过14天为12%,总体28天死亡率为26.4%。发病第一周入住者SOFA评分更高、血小板减少或急性肾损伤更常见、影像学受累更有限、血IL-6水平显著更高。年龄、COPD、免疫抑制状态、发病至入住时间、肌钙蛋白浓度和急性肾损伤与死亡率独立相关。
要点
- 发病第一周入住ICU者SOFA评分更高,血小板减少或急性肾损伤更常见,血IL-6水平显著更高。
- 发病第一周入住者影像学受累更有限,提示非呼吸系统严重程度更高。
- 年龄、COPD、免疫抑制状态、发病至ICU入住时间、肌钙蛋白浓度和急性肾损伤与28天死亡率独立相关。
- 作者认为针对SARS-CoV-2的治疗干预可能根据发病后时间影响不同的临床终点。
适用人群与场景
- 2020年2月20日至4月24日收治于四家ICU的379例COVID-19患者。
- 中位年龄66岁(53-68),292例(77%)为男性。
- 主要合并症包括肥胖和超重(67%)、高血压(49.6%)和糖尿病(30.1%)。
研究设计与关键结果
- 多中心回顾性研究,纳入379例COVID-19患者,按发病至ICU入住时间分组:161例(42.5%)在发病一周内入住,173例(45.6%)在8至14天入住,42例(11.1%)在超过14天入住。
- 发病至ICU入住中位时间为8天(6-11),3例缺失。
- 发病第一周入住者SOFA评分更高,血小板减少或急性肾损伤更常见,影像学受累更有限,血IL-6水平显著更高。
- Cox比例风险模型显示年龄、COPD、免疫抑制状态、发病至ICU入住时间、肌钙蛋白浓度和急性肾损伤与28天死亡率独立相关。
证据类型、等级与局限
- 研究类型:多中心回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为针对SARS-CoV-2的治疗干预可能根据发病后时间影响不同的临床终点。
- 发病一周内入住ICU的COVID-19患者非呼吸系统严重程度更高,死亡率更高,临床评估需关注呼吸系统以外的器官功能。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
- 另有 2 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开
PURPOSE: Coronavirus disease 2019 (COVID-19) is creating an unprecedented healthcare crisis. Understanding the determinants of mortality is crucial to optimise intensive care unit (ICU) resource use and to identify targets for improving survival.
METHODS: In a multicentre retrospective study, we included 379 COVID-19 patients admitted to four ICUs between 20 February and 24 April 2020 and categorised according to time from disease onset to ICU admission. A Cox proportional-hazards model identified factors associated with 28-day mortality.
RESULTS: Median age was 66 years (53-68) and 292 (77%) were men. The main comorbidities included obesity and overweight (67%), hypertension (49.6%) and diabetes (30.1%). Median time from disease onset (i.e., viral symptoms) to ICU admission was 8 (6-11) days (missing for three); 161 (42.5%) patients were admitted within a week of disease onset, 173 (45.6%) between 8 and 14 days, and 42 (11.1%) > 14 days after disease onset; day 28 mortality was 26.4% (22-31) and decreased as time from disease onset to ICU admission increased, from 37 to 21% and 12%, respectively. Patients admitted within the first week had higher SOFA scores, more often had thrombocytopenia or acute kidney injury, had more limited radiographic involvement, and had significantly higher blood IL-6 levels. Age, COPD, immunocompromised status, time from disease onset, troponin concentration, and acute kidney injury were independently associated with mortality.
CONCLUSION: The excess mortality in patients admitted within a week of disease onset reflected greater non-respiratory severity. Therapeutic interventions against SARS-CoV-2 might impact different clinical endpoints according to time since disease onset.
参考来源
- Azoulay E, Fartoukh M, Darmon M, et al. Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset. Intensive Care Med. 2020. PMID: 32780165. doi:10.1007/s00134-020-06202-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。